Page last updated: 2024-08-22

enbucrilate and Allergic Encephalomyelitis

enbucrilate has been researched along with Allergic Encephalomyelitis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Glushkova, OV; Khrenov, MO; Lunin, SM; Novoselova, EG; Novoselova, TV; Parfenyuk, SB	1

Other Studies

1 other study(ies) available for enbucrilate and Allergic Encephalomyelitis

Article	Year
Protective Effect of PBCA Nanoparticles Loaded with Thymulin Against the Relapsing-Remitting Form of Experimental Autoimmune Encephalomyelitis in Mice. International journal of molecular sciences, 2019, Oct-29, Volume: 20, Issue:21 Topics: Animals; Cytokines; Disease Models, Animal; Enbucrilate; Encephalomyelitis, Autoimmune, Experimental; Female; HSP72 Heat-Shock Proteins; Interleukin-17; Mice; Multiple Sclerosis, Relapsing-Remitting; Nanoparticles; NF-kappa B; Particle Size; Phosphorylation; Thymic Factor, Circulating; Transcription Factor RelA; Tumor Suppressor Protein p53	2019

Article

Year

Protective Effect of PBCA Nanoparticles Loaded with Thymulin Against the Relapsing-Remitting Form of Experimental Autoimmune Encephalomyelitis in Mice.

International journal of molecular sciences, 2019, Oct-29, Volume: 20, Issue:21

Topics: Animals; Cytokines; Disease Models, Animal; Enbucrilate; Encephalomyelitis, Autoimmune, Experimental; Female; HSP72 Heat-Shock Proteins; Interleukin-17; Mice; Multiple Sclerosis, Relapsing-Remitting; Nanoparticles; NF-kappa B; Particle Size; Phosphorylation; Thymic Factor, Circulating; Transcription Factor RelA; Tumor Suppressor Protein p53

2019